Tom Kay is Director of St Vincent’s Institute of Medical Research and the newly established Aikenhead Centre at St. Vincent’s in Melbourne, as well as continuing an active role in SVI’s type 1 diabetes research group. He is Chief Investigator “A” on an NHMRC Program Grant entitled “Pathogenesis-based Treatment of Type 1 Diabetes”. As an endocrinologist and clinical immunologist he leads the Victorian node of the Australian Islet Transplant Consortium. His research interests include the immune mechanisms by which insulinproducing beta cells are destroyed in diabetes and proinsulin-specific immune tolerance. Tom is Secretary of the International Pancreas and Islet Transplant Association (IPITA) and the immediate Past President of The Immunology of Diabetes Society (IDS). He was Convenor of the 13th Congress of IDS in December 2013 and Convenor of the IPITA/IXA/CTS Joint Congress in 2015.